Molecular jackhammers: a breakthrough in cancer treatment
Share this article:
In short: Researchers in Texas have developed aminocyanine molecules—or “molecular jackhammers”—that are activated by near-infrared light to vibrate at very high frequencies and mechanically tear apart tumor cell membranes. In the laboratory, this approach destroys up to 99% of cancer cells and achieves a 50% remission rate in mice, without heat or chemical toxicity. While distinct from photobiomodulation, it remains complementary to it.
An innovative technology uses vibrating molecules activated by infrared light to eliminate up to 99% of cancer cells in the laboratory.
A major breakthrough in photomedicine
Researchers in Texas have demonstrated that certain molecules, known as aminocyanines, can be activated by infrared light to vibrate at very high frequencies. These mechanical vibrations, known as Directed Vibronic Action, rupture the cell membranes of tumors without the use of heat or conventional chemical reactions.
Preclinical results by the numbers
99% of cancer cells destroyed in culture
50% complete remission in mice
10 cm of tissue penetration (NIR light)
Vibrations at 40 trillion cycles per second
These results far exceed those of current treatments.
A unique mechanism of action
Unlike chemotherapy, this approach does not rely on toxic substances but on a physical effect. It works even at low temperatures (2 °C) and does not depend on the presenceof oxygen or free radicals.
A revolution in photobiomodulation?
These molecular jackhammers introduce a new light therapy modality that complements photobiomodulation. PBM could be used before or after treatment to stimulate cell regeneration or optimize the immune response.
Good to know : This approach could soon be incorporated into professional LED devices used in oncology.
Frequently Asked Questions
What is a molecular jackhammer?
It is a molecule activated by infrared light that vibrates at a high frequency and physically destroys cancer cells.
Is this technique available?
Not yet. Human clinical trials are expected to begin in 5 to 7 years.
Is this a form of photobiomodulation?
No, it's a new method based on a mechanical action, but it complements traditional PBM.
Scientific sources cited
Molecular jackhammers eradicate cancer cells through vibronic-driven action James Tour, Ciceron Ayala-Orozco et al. Nature Chemistry, 2023 https://www.nature.com/articles/s41557-023-01383-y Explains the mechanism of molecular vibrations activated by near-infrared light.
Molecular jackhammers: Good vibrations eradicate cancer cells Science Alert, 2023 https://www.sciencealert.com/scientists-destroy-99-of-cancer-cells-in-the-lab-using-vibrating-molecules A layman’s summary of the preclinical results, with key figures.
PubMed - Vibronic-driven action and cancer remission in mice PubMed ID: 38114816 https://pubmed.ncbi.nlm.nih.gov/38114816/ Confirms the remission observed in mouse models of melanoma.
Our summary of the 58 publications on photobiomodulation that were published or indexed in June 2026. Topics include: oral mucositis confirmed by a multicenter randomized trial; PBM for pain associated with temporomandibular disorders; and more recent research in cognition, sleep, and presbyopia.
Photobiomodulation and Chemotherapy: The Study That Restores Memory
A study by the Valenciennes Hospital (CHV) confirms that transcranial photobiomodulation (using the Vielight Duo 4 headset) restores memory after chemotherapy: 93.5% of patients showed improvement.
Our May 2026 scientific review compiles 30 publications on photobiomodulation, including several meta-analyses and randomized trials. Overview by clinical field: pain, supportive oncology, neurology, oral health, sports medicine, wound healing, and ophthalmology.
As of April 2026, 144 PubMed publications on photobiomodulation had been indexed. Our team selected 18 notable clinical studies in the fields of neurology, supportive oncology, ophthalmology, dentistry, sports medicine, and pain management.